Prevention of diseases in children born by caesarean section

摘要

1. Use of a composition comprising non-digestible oligosaccharides for preparing a composition for the treatment and / or prevention of disorders in infants born via caesarean section, wherein the disorder is selected from the group consisting of allergy, asthma, infection and atopic dermatitis. ! 2. Use according to claim 1, wherein the infection is selected from the group consisting of infections caused by Esherichia coli, Streptococcus, Clostridium, Bacillus, Pseudomonas, Enterobacter, Klebsiella, Acinetobacter, Proteus, Aeromonas. ! 3. The use according to any preceding claim, wherein the composition comprises at least one non-digestible oligosaccharide selected from the group consisting of galactooligosaccharides, indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides (including gentsiooligosaharidy and cyclodextrins), chitooligosaccharides, fucooligosaccharides, mannooligosaccharides, isomaltooligosaccharides , fructo-oligosaccharides (including inulin), arabinogalaktooligosaharidov, glyukomannooligosaharidov and galactomanno at. ! 4. Use according to claim 1, wherein the composition contains from 0.5 to 75 grams indigestible oligosaccharide per 100 gram dry weight of the composition. ! 5. Use of a composition comprising non-digestible oligosaccharide for the preparation of a composition for (i) treatment and / or prevention of disorders in infants born by caesarean section and / or (ii) improve the health of children born by caesarean section, wherein: a) the composition comprises at least one non-digestible oligosaccharide selected from the group consisting of galactooligosaccharides, indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides (in